OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · IEX Real-Time Price · USD
2.20
0.00 (0.00%)
Jul 5, 2022 3:59 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Year | 2020 | 2019 |
|---|---|---|
| Selling, General & Admin
|
3.19 | 1.02 |
| Research & Development
|
0.17 | 0.52 |
| Operating Expenses
|
3.37 | 1.53 |
| Operating Income
|
-3.37 | -1.53 |
| Interest Expense / Income
|
0 | 0 |
| Other Expense / Income
|
0.01 | 0.08 |
| Pretax Income
|
-3.38 | -1.62 |
| Income Tax
|
-0.02 | -0.08 |
| Net Income
|
-3.35 | -1.54 |
| Net Income Common
|
-3.35 | -1.54 |
| Shares Outstanding (Basic)
|
1,407 | - |
| EPS (Basic)
|
-0.65 | - |
| EPS (Diluted)
|
-0.65 | - |
| Free Cash Flow Per Share
|
-0.07 | - |
| Effective Tax Rate
|
0.74% | 4.71% |
| EBITDA
|
-3.37 | -1.61 |
| Depreciation & Amortization
|
0.01 | 0.01 |
| EBIT
|
-3.38 | -1.62 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).